Cargando…

Serum vitamin D in patients with mild cognitive impairment and Alzheimer's disease

OBJECTIVES: To determine the relevance of Mini‐Mental State Examination (MMSE), serum 25‐hydroxyvitamin D (25(OH)D3), and 1,25(OH)2D3 concentrations to mild cognitive impairment (MCI) and various stages of Alzheimer's disease (AD). MATERIALS AND METHODS: The study included 230 participants (>...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ouma, Shinji, Suenaga, Midori, Bölükbaşı Hatip, Funda F., Hatip‐Al‐Khatib, Izzettin, Tsuboi, Yoshio, Matsunaga, Yoichi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5840452/ https://www.ncbi.nlm.nih.gov/pubmed/29541546 http://dx.doi.org/10.1002/brb3.936

Ejemplares similares

Circulatory 25(OH)D and 1,25(OH)(2)D as differential biomarkers between multiple system atrophy and Parkinson's disease patients
por: Ogura, Hiromu, et al.
Publicado: (2021)

Role of cytochrome P450 for vitamin D metabolisms in patients with neurodegenerative disorders
por: Kakimoto, Asako, et al.
Publicado: (2022)

Environmental Factors Preceding Aβ40 Monomer to Oligomers and the Detection of Oligomers in Alzheimer's Disease Patient Serum
por: Matsunaga, Yoichi, et al.
Publicado: (2012)

Sensitive determination of hydrazine using poly(phenolphthalein), Au nanoparticles and multiwalled carbon nanotubes modified glassy carbon electrode
por: HATİP, Müge, et al.
Publicado: (2021)

The efficacy and safety of hachimijiogan for mild Alzheimer disease in an exploratory, open standard treatment controlled, randomized allocation, multicenter trial: A study protocol
por: Kainuma, Mosaburo, et al.
Publicado: (2020)

Efficacy and Blood Plasmalogen Changes by Oral Administration of Plasmalogen in Patients with Mild Alzheimer's Disease and Mild Cognitive Impairment: A Multicenter, Randomized, Double-blind, Placebo-controlled Trial
por: Fujino, Takehiko, et al.
Publicado: (2017)

Cognitive Blackouts in Mild Cognitive Impairment and Alzheimer's Dementia
por: Adler, Georg, et al.
Publicado: (2018)

Writing Impairments in Japanese Patients with Mild Cognitive Impairment and with Mild Alzheimer's Disease
por: Hayashi, Atsuko, et al.
Publicado: (2015)

Spatial inhibition of return is impaired in mild cognitive impairment and mild Alzheimer’s disease
por: Jiang, Xiong, et al.
Publicado: (2021)

A New Serum Biomarker Set to Detect Mild Cognitive Impairment and Alzheimer’s Disease by Peptidome Technology
por: Abe, Koji, et al.
Publicado: (2020)

The Fornix in Mild Cognitive Impairment and Alzheimer’s Disease
por: Nowrangi, Milap A., et al.
Publicado: (2015)

Judgment in Mild Cognitive Impairment and Alzheimer's disease
por: Capucho, Patrícia Helena Figueirêdo Vale, et al.
Publicado: (2011)

Protection against Brain Atrophy by Anti-dementia Medication in Mild Cognitive Impairment and Alzheimer’s Disease: Meta-Analysis of Longitudinal Randomized Placebo-Controlled Trials
por: Kishi, Taro, et al.
Publicado: (2015)

Plasma Homocysteine and Serum Folate and Vitamin B(12) Levels in Mild Cognitive Impairment and Alzheimer’s Disease: A Case-Control Study
por: Ma, Fei, et al.
Publicado: (2017)

Different Characteristics of Cognitive Impairment in Elderly Schizophrenia and Alzheimer's Disease in the Mild Cognitive Impairment Stage
por: Kazui, Hiroaki, et al.
Publicado: (2011)

Disproportionate Decline of Executive Functions in Early Mild Cognitive Impairment, Late Mild Cognitive Impairment, and Mild Alzheimer's Disease
por: Kim, Sangsoon, et al.
Publicado: (2016)

Estimation of Tau and Phosphorylated Tau(181) in Serum of Alzheimer’s Disease and Mild Cognitive Impairment Patients
por: Shekhar, Shashank, et al.
Publicado: (2016)

The Differences of Serum Metabolites Between Patients With Early-Stage Alzheimer's Disease and Mild Cognitive Impairment
por: Weng, Wei-Chieh, et al.
Publicado: (2019)

Automatic morphometry in Alzheimer's disease and mild cognitive impairment()()
por: Heckemann, Rolf A., et al.
Publicado: (2011)

Brain imaging of mild cognitive impairment and Alzheimer's disease
por: Yin, Changhao, et al.
Publicado: (2013)

Targeting norepinephrine in mild cognitive impairment and Alzheimer's disease
por: Chalermpalanupap, Termpanit, et al.
Publicado: (2013)

Anosognosia and Anosodiaphoria in Mild Cognitive Impairment and Alzheimer's Disease
por: Lindau, Maria, et al.
Publicado: (2014)

Prospective memory in Alzheimer’s disease and Mild Cognitive Impairment
por: Spíndola, Lívia, et al.
Publicado: (2011)

Assessment for apraxia in mild cognitive impairment and Alzheimer's dise
por: Ward, Mirela, et al.
Publicado: (2015)

Peripheral reaching in Alzheimer's disease and mild cognitive impairment
por: Mitchell, Alexandra G., et al.
Publicado: (2022)

Olfactory memory in mild cognitive impairment and Alzheimer’s disease
por: Audronyte, Egle, et al.
Publicado: (2023)

Cognitive Impairment Precedes and Predicts Functional Impairment in Mild Alzheimer’s Disease
por: Liu-Seifert, Hong, et al.
Publicado: (2015)

Paraoxonase 1, B Vitamins Supplementation, and Mild Cognitive Impairment
por: Perła-Kaján, Joanna, et al.
Publicado: (2021)

Mild behavioral impairment linked to progression to Alzheimer’s disease and cortical thinning in amnestic mild cognitive impairment
por: Yoon, Eun Jin, et al.
Publicado: (2023)

Hyperbaric oxygen ameliorates cognitive impairment in patients with Alzheimer's disease and amnestic mild cognitive impairment
por: Chen, Jianwen, et al.
Publicado: (2020)

Abnormal Cortical Networks in Mild Cognitive Impairment and Alzheimer's Disease
por: Yao, Zhijun, et al.
Publicado: (2010)

Are NSAIDs Useful to Treat Alzheimer's Disease or Mild Cognitive Impairment?
por: Imbimbo, Bruno P., et al.
Publicado: (2010)

Diffusion Tensor Imaging in Alzheimer’s Disease and Mild Cognitive Impairment
por: Stebbins, G. T., et al.
Publicado: (2009)

Elevated Osteopontin Levels in Mild Cognitive Impairment and Alzheimer's Disease
por: Sun, Yuan, et al.
Publicado: (2013)

LDL Phenotype in Subjects with Mild Cognitive Impairment and Alzheimer’s Disease
por: Vikarunnessa, Sheikh, et al.
Publicado: (2013)

A Depressive Endophenotype of Mild Cognitive Impairment and Alzheimer’s Disease
por: Johnson, Leigh A., et al.
Publicado: (2013)

Directed Network Motifs in Alzheimer’s Disease and Mild Cognitive Impairment
por: Friedman, Eric J., et al.
Publicado: (2015)

Retinal blood flow in mild cognitive impairment and Alzheimer's disease
por: Feke, Gilbert T., et al.
Publicado: (2015)

The Alzheimer’s disease metabolic brain pattern in mild cognitive impairment
por: Meles, Sanne K, et al.
Publicado: (2017)

Progranulin levels in blood in Alzheimer's disease and mild cognitive impairment
por: Cooper, Yonatan A., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_i7o5t3vh3dtcmr5pu0g6sv06d8